The MaxCyte, Inc. VLX Large Scale Transfection System for Protein and Antibody Production is Launched at PepTalk 2012  
1/9/2012 8:24:07 AM

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, is hosting a series of events at CHI’s PepTalk 2012 being held January 9-13 in San Diego. The highlighted event will be the introduction of the MaxCyte® VLX™ Large Scale Transfection System which has the capability to transfect up to 2E11 cells in less than 30 minutes with high efficiency and high viability, dramatically extending the gram-scale protein bioproduction capabilities of the current MaxCyte instrument product line.